entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 19:26:12 Page View：9

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare drug price lawsuits could be good politics for Biden
Next article： Bright Health sells Medicare Advantage business to Molina

Wikipedia

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Think you might have Covid

AdobeIfyouhaveacough,fever,orshortnessofbreath,howcanyoutellifyou’vegotCovid-19,acommoncold,theordin

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

MollyFerguson/STATHello!SometakesandthoughtsonGilead’sTrodelvytroubles,ElevationOncology’ssurprising

entertainment

explore

Wikipedia

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise